Latest stories

  • in

    Interpersonal therapy benefits pregnant women to combat depression: JAMA

    United States: An original investigation published in JAMA Psychiatry has addressed the role of IPT, brief interpersonal therapy, in depression among pregnant women. It is encouraging to mention that IPT reduces depression relatively quickly after initiation of treatment. The recipients are benefited from treatment regardless of baseline Major Depressive Disorder or MDD status, or GA […] More

  • in

    Prenatal depression and cardiovascular disease after childbirth may be linked: Study

    The negative effects of depression on cardiovascular health in the general population are well established: depressed men and women are more likely to develop heart disease later in life, and previous research has found that about 20% of individuals experience depression during pregnancy. However, little research has been done on prenatal depression as a specific […] More

  • in

    Depression negatively affects breast cancer patients’ survival: Study

    Having depression before or after a breast cancer diagnosis was associated with a lower likelihood of survival, in a recent study. The findings are published by Wiley online in CANCER, a peer-reviewed journal of the American Cancer Society. For the study, Bin Huang, DrPH, of the University of Kentucky Markey Cancer Center, and his colleagues […] More

  • in

    Cognitive Depression: New Study Says Probiotics Can Help Ease Symptoms

    The discussion on mental health issues are being held more and more these days. There were several stigmas attached to it in the generations that came before ours. Even in the 21st century some people struggle to open up about their own mental state. However, the resources required to treat any kind of issues related […] More

  • in

    Zydus Lifesciences Depression drug Doxepin Hydrochloride bags USFDA okay

    Ahmedabad: Pharma major, Zydus Lifesciences Limited, has announced that the company has received final approval for Doxepin Hydrochloride Capsules USP, 150 mg (USRLD: Sinequan Capsules) from the United States Food and Drug Administration (USFDA). Doxepin Hydrochloride capsule is indicated to treat mental/mood problems such as depression and anxiety. It helps improve moods and feelings of […] More